Inpefa

Drug Lexicon Pharmaceuticals, Inc.
Total Payments
$2.3M
Transactions
18,951
Doctors
9,793
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $1.7M 3,666 1,888
2023 $647,382 15,285 8,501

Payments by Nature

Nature of Payment Amount Transactions Share
Honoraria $1.4M 517 62.9%
Food and Beverage $539,605 17,484 23.4%
Travel and Lodging $190,798 924 8.3%
Consulting Fee $99,930 20 4.3%
Unspecified $15,764 2 0.7%
Space rental or facility fees (teaching hospital only) $5,000 1 0.2%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,213 2 0.1%
Grant $1,200 1 0.1%

Payments by Type

General
$2.3M
18,949 transactions
Research
$15,764
2 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
Effects of Sotagliflozin in regulation of clotting and thrombotic Risk Lexicon Pharmaceuticals, Inc. $11,164 0
LX9211.1-204-DPN-A Phase 2b, Dose-ranging, Randomized, Double-blind, Placebo-controlled, Parallel-Group, Multicenter Study with an Open0label Extension in Patients with Diabetic Peripheral Neurophathic Pain. Lexicon Pharmaceuticals, Inc. $4,600 0

Top Doctors Receiving Payments for Inpefa — Page 391

Doctor Specialty Location Total Records
, DO Family Medicine Grand Blanc, MI $12.77 1
, D.O Family Medicine Grand Blanc, MI $12.77 1
, APRN Acute Care Kansas City, MO $12.77 1
, MD Family Medicine Bismarck, ND $12.75 1
, MD Family Medicine Bismarck, ND $12.74 1
Amy Gotvaslee Nurse Practitioner Bismarck, ND $12.74 1
, PA Physician Assistant Bismarck, ND $12.74 1
, MD Family Medicine Bismarck, ND $12.74 1
, MD Family Medicine Bismarck, ND $12.74 1
, APRN Family Medicine Bismarck, ND $12.74 1
, PA Physician Assistant Indianapolis, IN $12.72 1
, D.O Internal Medicine Lewisburg, PA $12.72 1
, M.D Interventional Cardiology Mesa, AZ $12.72 1
, DO Internal Medicine Lewisburg, PA $12.72 1
, MD Cardiovascular Disease Longview, TX $12.72 1
, M.D Internal Medicine Winter Park, FL $12.72 1
Meaghan Stutesman Family Indianapolis, IN $12.72 1
, MD Internal Medicine Danville, PA $12.72 1
, APRN Adult Health Indianapolis, IN $12.72 1
, MD Cardiovascular Disease Winter Park, FL $12.72 1
, CRNP Nurse Practitioner Lewisburg, PA $12.72 1
, DO Cardiovascular Disease Indianapolis, IN $12.72 1
, NP Registered Nurse Indianapolis, IN $12.72 1
Christopher Healy Student in an Organized Health Care Education/Training Program Indianapolis, IN $12.71 1
, NP Nurse Practitioner Greenville, TX $12.71 1

About Inpefa

Inpefa is a drug associated with $2.3M in payments to 9,793 healthcare providers, recorded across 18,951 transactions in the CMS Open Payments database. The primary manufacturer is Lexicon Pharmaceuticals, Inc..

Payment data is available from 2023 to 2024. In 2024, $1.7M was paid across 3,666 transactions to 1,888 doctors.

The most common payment nature for Inpefa is "Honoraria" ($1.4M, 62.9% of total).

Inpefa is associated with 2 research studies, including "Effects of Sotagliflozin in regulation of clotting and thrombotic Risk" ($11,164).